These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33663671)
1. [Histone Deacetylase Inhibitors in the in Vitro Expansion of Hematopoietic Stem Cells]. Chen M; Zhuang JL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):109-115. PubMed ID: 33663671 [TBL] [Abstract][Full Text] [Related]
2. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor. Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors. Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo. Lam YM; Chan YF; Chan LC; Ng RK Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells. Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388 [TBL] [Abstract][Full Text] [Related]
8. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. Qiao Y; Wang R; Yang X; Tang K; Jing N J Biol Chem; 2015 Jan; 290(4):2508-20. PubMed ID: 25519907 [TBL] [Abstract][Full Text] [Related]
9. Murine hematopoietic stem cell dormancy controlled by induction of a novel short form of PSF1 by histone deacetylase inhibitors. Han Y; Gong ZY; Takakura N Exp Cell Res; 2015 Jun; 334(2):183-93. PubMed ID: 25933513 [TBL] [Abstract][Full Text] [Related]
10. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. Wang Y; Chen T; Yan H; Qi H; Deng C; Ye T; Zhou S; Li FR J Cell Biochem; 2013 Oct; 114(10):2231-9. PubMed ID: 23564418 [TBL] [Abstract][Full Text] [Related]
11. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. Chaurasia P; Berenzon D; Hoffman R Blood; 2011 Apr; 117(17):4632-41. PubMed ID: 21355088 [TBL] [Abstract][Full Text] [Related]
12. High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line. Yamato E Endocr Regul; 2018 Jan; 52(1):21-26. PubMed ID: 29453918 [TBL] [Abstract][Full Text] [Related]
13. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Kawano Y; Nasu K; Li H; Tsuno A; Abe W; Takai N; Narahara H Hum Reprod; 2011 Sep; 26(9):2486-98. PubMed ID: 21715447 [TBL] [Abstract][Full Text] [Related]
14. Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development. Li Q; Foote M; Chen J Sci Rep; 2014 Nov; 4():7207. PubMed ID: 25423891 [TBL] [Abstract][Full Text] [Related]
15. Ex Vivo Expansion of Adult Hematopoietic Stem and Progenitor Cells with Valproic Acid. Papa L; Djedaini M; Kintali M; Schaniel C; Hoffman R Methods Mol Biol; 2021; 2185():267-280. PubMed ID: 33165854 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure. Qiu X; Rong X; Yang J; Lu Y BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701 [TBL] [Abstract][Full Text] [Related]
17. Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function. Walasek MA; Bystrykh LV; Olthof S; de Haan G; van Os R Exp Hematol; 2013 Jan; 41(1):113-23.e2. PubMed ID: 22989761 [TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid. Papa L; Djedaini M; Hoffman R J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033947 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors. Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]